INTRODUCTION
Amyloid beta (A,) is the major constituent of the fibrils composing senile plaques and vascular deposits in Alzheimer's disease (AD) and related disorders. It is an internal degradation product (39-42 residues) of a larger precursor (amyloid precursor protein, APP) generated through still-unclear proteolytic mechanisms (for a review, see [1] ). So far, two main APPprocessing pathways have been described. Pathway I involves a proteolytic cleavage inside the A/I sequence that prevents amyloid formation [2] [3] [4] [5] . Pathway II, in contrast, generates N-terminal fragments of APP lacking A/I [6] and C-terminal peptides containing intact A,I. These fragments have been described in membrane-associated fractions isolated from cerebral cortex, leptomeningeal vessels, cerebral microvessels, baculovirusinfected Sf9 cells overexpressing APP and cell lines stably transfected with full-length APP [7] [8] [9] [10] [11] [12] [13] [14] . Very recently, soluble A/-like peptides (sA/) were identified in media from cell cultures of untransfected and APP-transfected cells as well as in cerebrospinal fluid (CSF) and plasma obtained from normal and AD patients [15] [16] [17] . Amino-acid-sequence analysis indicated that sA/I is similar to the amyloid protein extracted from cerebrovascular lesions.
Synthetic peptides identical with A/I have been used to study different physicochemical properties of A/I, among them cell adhesion and fibril formation [8, [18] [19] [20] [21] . A/I is able to promote cell adhesion by an interaction of the sequence RHDS (one-letter amino acid code; positions [5] [6] [7] [8] with an integrin-like receptor [8] .
Synthetic peptides identical with residues 1-40 of A,8 and their shorter derivatives SP28 (A/I1-28) and SP12 (A/I17-2.) spontaneously form fibrils in vitro [18] [19] [20] . Moreover, the presence of the Dutch mutation at codon 618 of APP696 [22] [18] and LGNNIHQWCGSNSNRYERC (SPl9, amino acids 196-215 of human plasma gelsolin) [25] were available in the laboratory. Sequences were corroborated via amino-acid-sequence analysis. BSA and keyhole-limpet haemocyanin (KLH) were from Sigma.
Peptide AfllAo was used to obtain anti-Afl140 polyclonal Of the above-described affinity matrices equilibrated with TBS, 2 ml were allowed to interact in batch with either 10 ml of human plasma or 30 ml ofCSF for 3 h at 37 'C, under continuous rotation. Unbound material was removed by extensive washing of the matrix with PBS, and the bound fraction was eluted using 1 M acetic acid, pH 2.5. Samples were dialysed against distilled deionized water and freeze-dried. In order to detect any remaining bound protein, 100 jul of beads were mixed with 50 j1 of sample buffer (2% SDS in 0.1 M Tris/HCl buffer, pH 6.8), containing 100 mM dithiothreitol (DDT), and boiled for 5 min before electrophoresis.
Amino acid sequence
Automatic Edman degradation analyses were carried out on a 477A protein sequencer, and the resulting phenylthiohydantoin derivatives identified using an on-line 120A phenylthiohydantoinderivative analyser (Applied Biosystems, Foster City, CA, U.S.A.). When necessary, samples were electrophoresed on an SDS/10%-polyacrylamide [27] Minigel and transferred on to poly(vinylidene difluoride) (PVDF) membranes (Immobilon; Millipore) using 3-cyclohexylamino-l-propanesulphonic acid, 
RESULTS AND DISCUSSION
In order to identify potential physiological ligands for sAfl, a synthetic peptide, Afl81o, was immobilized on to an affinity matrix and allowed to interact with either plasma or CSF obtained from normal donors. Af8lq0-Sepharose was able to retain a small amount of the total protein applied. From 10 ml of plasma, 260 jug were recovered in the bound fraction, representing approx. 0.04 % of the total protein applied, whereas 24 ApoJ or human plasma clusterin) ( Figure Ib) . The results were corroborated via immunoblot analysis using two monoclonal antibodies against SP-40,40 a-and ,-chains. As shown in Figure   1( [30] . The gene for SP-40,40 maps to chromosome 8 [31, 32] , and cDNA sequence studies indicated that the two chains are coded in a single open reading frame on the same mRNA molecule [33] . 40 functions as an inhibitor of the cytolytic terminal complement complex C5b-9 (also termed membrane-attack complex, MAC). It is present in the cytolytically inactive and watersoluble sC5b-9 complex, whereas it is absent in the membranebound C5b-9 complex, suggesting that SP-40,40 likely functions as an inhibitor similar to S-protein (vitronectin), possibly by binding to nascent metastable C5b-7 in conjunction with Sprotein [34, 35] . SP-40,40 is normally present in serum ,ug/ml) [28] , although it is about four times more concentrated in seminal fluid [36] , where it is known as clusterin, a major secreted product of Sertoli cells [37] [38] [39] .
SP-40,40 (also named ApoJ) has been identified in human plasma associated with high-density lipoproteins [40] , and its mRNA distribution indicates high levels of expression in the brain [41] . SP-40,40 has been quantified in CSF of normal individuals and AD patients [42] . The [42, 43] and S-protein [45] in amyloid plaques, adds further complexity to the speculation that the complement system plays a role in the tissue damage associated with senile plaques.
Several proteins (L-x-antichymotrypsin [46] , P-component [47] , proteoglycans [48] and ApoE [49] ) have been also found accumulated in Aft amyloid deposits, leading to the concept of 'pathological chaperones' (unrelated proteins that mediate ft-pleated amyloid formation [49] ). ApoE can also be retrieved from CSF or plasma using either affinity chromatography with Afljo or binding to A,8 on membranes; however, the elution conditions are completely different from those required by SP-40,40 [27a] .
It is noteworthy that both SP-40,40 (ApoJ) and ApoE have intriguing structural and functional similarities. Since both proteins can exist in plasma and compartments separated by a physiological barriers (i.e. blood/brain barrier), they can transport lipids, fatty acids and hydrophobic compounds between organs and facilitate lipid transport among cells within a particular organ [41] . Moreover, hybridization experiments in situ indicate that ApoJ is expressed by a variety of cells lining fluid compartments [50] ; therefore ApoJ may play an important role in preserving cell membranes from hydrophobic elements. The interaction of A,f with apolipoproteins, which may be involved in maintaining the solubility of Aft in biological fluids, points to a potential mechanism of membrane protection and sAft transport through the blood-brain barrier.
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